Related Experiment Video
Updated: May 31, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells
Jan-Gowth Chang1, Den-Mei Yang, Wen-Hsin Chang
1Department of Medical Research, University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. jgchang@ms.kmuh.org.tw
Abstract:
Alternative splicing involves differential exon selection of a gene transcript to generate mRNA and protein isoforms with structural and functional diversity. Abnormal alternative splicing has been shown to be associated with malignant phenotypes of cancer cells, such as chemo-resistance and invasive activity. Screening small molecules and drugs for modulating RNA splicing in human hepatocellular carcinoma cell line Huh-7, we discovered that amiloride, distinct from four pH-affecting amiloride analogues, could "normalize" the splicing of BCL-X, HIPK3 and RON/MISTR1 transcripts. Our proteomic analyses of amiloride-treated cells detected hypo-phosphorylation of splicing factor SF2/ASF, and decreased levels of SRp20 and two un-identified SR proteins. We further observed decreased phosphorylation of AKT, ERK1/2 and PP1, and increased phosphorylation of p38 and JNK, suggesting that amiloride treatment down-regulates kinases and up-regulates phosphatases in the signal pathways known to affect splicing factor protein phosphorylation. These amiloride effects of "normalized" oncogenic RNA splicing and splicing factor hypo-phosphorylation were both abrogated by pre-treatment with a PP1 inhibitor. Global exon array of amiloride-treated Huh-7 cells detected splicing pattern changes involving 584 exons in 551 gene transcripts, many of which encode proteins playing key roles in ion transport, cellular matrix formation, cytoskeleton remodeling, and genome maintenance. Cellular functional analyses revealed subsequent invasion and migration defects, cell cycle disruption, cytokinesis impairment, and lethal DNA degradation in amiloride-treated Huh-7 cells. Other human solid tumor and leukemic cells, but not a few normal cells, showed similar amiloride-altered RNA splicing with devitalized consequence. This study thus provides mechanistic underpinnings for exploiting small molecule modulation of RNA splicing for cancer therapeutics.
Insights
Amiloride normalizes cancer cell RNA splicing by affecting splicing factors and signaling pathways. This leads to reduced cancer cell invasion, migration, and survival, offering a potential new cancer therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- Alternative splicing generates diverse protein isoforms, and its dysregulation is linked to cancer malignancy, including chemo-resistance and invasion.
- Identifying small molecules that modulate RNA splicing is crucial for developing novel cancer therapeutics.
Purpose of the Study:
- To screen for small molecules that can modulate RNA splicing in human hepatocellular carcinoma (HCC) cells.
- To investigate the molecular mechanisms by which amiloride affects RNA splicing and cancer cell phenotypes.
- To explore the therapeutic potential of amiloride in cancer treatment.
Main Methods:
- Screening of small molecules for RNA splicing modulation in Huh-7 HCC cells.
- Proteomic analysis to identify changes in splicing factors and signaling pathway proteins.
- Global exon array analysis to detect splicing pattern alterations.
- Cellular functional assays to assess invasion, migration, cell cycle, and DNA integrity.
Main Results:
- Amiloride selectively "normalized" aberrant splicing of BCL-X, HIPK3, and RON/MISTR1 transcripts in Huh-7 cells.
- Amiloride treatment led to hypo-phosphorylation of splicing factor SF2/ASF and altered levels of other SR proteins.
- Proteomic analysis revealed amiloride-induced changes in kinase/phosphatase activity affecting splicing factor phosphorylation, which were reversible with a PP1 inhibitor.
- Global exon array identified widespread splicing changes in 551 genes, impacting various cellular functions.
- Amiloride treatment impaired cancer cell invasion, migration, cell cycle progression, and induced DNA degradation.
- Similar splicing alterations and cytotoxic effects were observed in other cancer cells, but not significantly in normal cells.
Conclusions:
- Amiloride acts as a novel RNA splicing modulator, distinct from its pH-altering effects.
- The mechanism involves down-regulation of specific kinases and up-regulation of phosphatases impacting splicing factor phosphorylation.
- Amiloride-induced splicing normalization and subsequent cellular defects present a promising avenue for cancer therapeutics.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
MicroRNAs
MicroRNAs

